The Orthopaedic Implant

The Orthopaedic Implant Company (OIC) operates with a mission to disrupt the conventional pricing and delivery of orthopedic implants. Founded in August 2010 by Itai Nemovicher and Dr. Peter Althausen, the company was born from the observation that many orthopedic devices had become commoditized, yet their prices remained high. Nemovicher, with his background as a sales manager for a major orthopedic brand, recognized the disconnect between implant costs and their intrinsic value. Dr. Althausen, a practicing orthopedic trauma surgeon, saw the rising out-of-pocket expenses for patients and questioned the value of sales representative presence in the operating room. This shared perspective on the need for better value in orthopedic devices was the catalyst for OIC's creation.

Based in Reno, Nevada, OIC manufactures and supplies orthopedic trauma implants, targeting surgeons, hospitals, and ambulatory surgery centers (ASCs). The company's business model is centered on providing high-quality, clinically equivalent implants at a significantly lower cost, often 50 to 60 percent less than the average market price. By creating better value, OIC aims to help healthcare facilities reduce costs without compromising the quality of patient care. This strategy allows hospitals to potentially pass savings on to patients, contributing to a more equitable healthcare system. The company's product portfolio is comprehensive, covering a wide range of common fracture treatments. Offerings include plates and screws, intramedullary (IM) nails, cannulated screws, external fixation devices, and systems for ankle, hand, and wrist fractures, as well as sports medicine solutions. OIC has achieved several milestones, including the launch of its DRPx wrist fracture plating system and an innovative Threaded Metacarpal Nail System.

In a significant development, Zeda, Inc. acquired OIC in February 2024. Under this acquisition, OIC operates as a Zeda Health company. The collaboration aims to leverage Zeda's additive manufacturing technologies with OIC's expertise in value-based implants to enhance the global accessibility and affordability of orthopedic care. This strategic move is expected to expand OIC's reach in providing cost-effective orthopedic solutions both in the U.S. and internationally.

Keywords: orthopedic trauma implants, value-based healthcare, medical device manufacturing, cost-effective implants, surgical implants, fracture fixation, orthopedic surgery solutions, hospital cost savings, ambulatory surgery centers, plates and screws, intramedullary nails, ankle fracture, wrist fracture, sports medicine implants, healthcare value, medical device acquisition, orthopedic device market, implant pricing disruption, clinical equivalency, Zeda Health, Itai Nemovicher, Peter Althausen, Reno medical devices, accessible orthopedic care